Targeting leukocyte trafficking for the treatment of inflammatory bowel disease.
about
Pathway-based approaches to the treatment of inflammatory bowel disease.Natalizumab in the treatment of Crohn's disease patients.Emerging therapeutic targets and strategies in Crohn's disease.Genetic risk variants as therapeutic targets for Crohn's disease.Pharmacokinetic and Pharmacodynamic Modeling of Serum Etrolizumab and Circulating β7 Receptor Occupancy in Patients With Ulcerative Colitis.INFERNO: inferring the molecular mechanisms of noncoding genetic variants
P2860
Targeting leukocyte trafficking for the treatment of inflammatory bowel disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Targeting leukocyte trafficking for the treatment of inflammatory bowel disease.
@en
type
label
Targeting leukocyte trafficking for the treatment of inflammatory bowel disease.
@en
prefLabel
Targeting leukocyte trafficking for the treatment of inflammatory bowel disease.
@en
P2860
P356
P1476
Targeting leukocyte trafficking for the treatment of inflammatory bowel disease.
@en
P2093
F Cominelli
K O Arseneau
P2860
P356
10.1002/CPT.6
P407
P577
2014-12-02T00:00:00Z